Nanoparticle and Liposome Based Novel Drug Delivery Systems
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (30 November 2018) | Viewed by 52501
Special Issue Editors
Interests: antibacterial activity; antimycoplasma activity; antiviral activity; natural extract; essential oils; coronavirus; probiotics; drug delivery development
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; nanomedicine; nanocarriers; biopolymers; pharmaceutical technology; ocular drug delivery; oral drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
"Drug delivery" is understood as the development of alternative systems for controlled and/or targeted distribution of drugs in the body. It can provide the opportunity to narrow the biological effects of a molecule directly to the target cell/tissue, by decreasing both the side effects and increasing its therapeutic efficacy, and, therefore, the intrinsic activity of a biomolecule.
Many studies in the literature have shown how both inefficiency and bioavailability can be addressed by improving one or the other, and in some cases both, through the use of specific colloidal (nanosized) carriers.
The purpose of this Special Issue will be to publish a series of original articles on sopramolecular drug delivery systems, with particular attention to new techniques of preparation and to all those new carrier systems used in modern pharmacotherapy of infectious and non-infectious diseases.
Technological aspects and proof-of-principle experimental findings will be accepted for this issue; however, papers dealing with in vivo data and pre-clinical or clinical transcriptional results will be highly welcomed.
Dr. Pio Maria Furneri
Prof. Dr. Rosario Pignatello
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- solid lipid nanoparticles (SLN)
- nanostructured lipid carriers (NLC)
- liposomes
- lipid nanocarriers
- nanoparticles
- polymeric nanoparticles
- intracellular distribution
- pharmacokinetics
- pharmacodynamics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.